GORE Flow Reversal System Cleared By FDA (Medical News Today)
W. L. Gore & Associates (Gore) announced at the International Congress on Endovascular Interventions XXII the US Food and Drug Administration (FDA) has given the company 510(k) clearance to market the GORE Flow Reversal System.

Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA (Centre Daily Times)
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) today announced that oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis (RRMS), has received a Fast Track designation from the U.S. Food and Drug Administration (FDA). Teva completed enrollment for the first of its two Phase III clinical trials for laquinimod ...

Guided Therapeutics, Inc. Reports Preliminary Findings From FDA Pivotal Clinical Trial (Medical News Today)
Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) today announced that its LightTouch non-invasive cervical cancer detection technology properly identified cervical disease missed by Pap tests and conventional pathology in a multi-site Food and Drug Administration (FDA) pivotal clinical trial.